MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Kite Pharma Company Profile (NASDAQ:KITE)

Consensus Ratings for Kite Pharma (NASDAQ:KITE) (?)
Ratings Breakdown: 8 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $81.86 (15.11% upside)

Analysts' Ratings History for Kite Pharma (NASDAQ:KITE)
Show:
DateFirmActionRatingPrice TargetActions
6/24/2015Jefferies GroupReiterated RatingBuy$83.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/24/2015Cowen and CompanyReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/24/2015MizuhoSet Price TargetBuy$90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/24/2015Canaccord GenuityReiterated RatingBuy$90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/18/2015Maxim GroupInitiated CoverageBuy$87.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2015Jefferies GroupReiterated RatingBuy$84.00 -> $83.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/18/2015Canaccord GenuitySet Price TargetBuy$90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2015Credit SuisseReiterated RatingOutperform$79.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2015Canaccord GenuitySet Price TargetBuy$90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/27/2015Credit SuisseSet Price TargetBuy$79.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2015MizuhoInitiated CoverageBuy$90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2015Credit SuisseSet Price TargetBuy$79.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2015Canaccord GenuityBoost Price TargetBuy$51.00 -> $90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2015Jefferies GroupBoost Price TargetBuy$46.00 -> $84.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/2/2015Credit SuisseBoost Price TargetOutperform$34.00 -> $71.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/15/2014Stifel NicolausBoost Price TargetBuy$45.00 -> $71.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/17/2014Jefferies GroupBoost Price TargetBuy$35.00 -> $46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/7/2014Canaccord GenuityReiterated RatingBuy$42.00 -> $51.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/28/2014Canaccord GenuityInitiated CoverageBuy$42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/21/2014Stifel NicolausBoost Price TargetBuy$31.00 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/2/2014GuggenheimInitiated CoverageBuy$73.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/19/2014Stifel NicolausInitiated CoverageBuy$31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/15/2014Citigroup Inc.Initiated CoverageBuy -> Outperform$31.00 -> $24.05View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/15/2014Cowen and CompanyInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/15/2014Credit SuisseInitiated CoverageOutperform$34.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/15/2014Jefferies GroupInitiated CoverageBuy$35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/15/2014Stifel NicolausInitiated CoverageBuy$31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/30/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha